Is Wegovy Getting Cheaper? What UK Prices Actually Look Like Right Now

Has the price of Wegovy actually fallen?

Not for most private patients. UK private pricing for Wegovy typically reflects the dose you are taking, the provider's overheads and what is bundled into the fee. Reported prices have generally ranged in the region of £149 to £375 per month depending on dose and supplier, though these figures shift and any individual quote can sit outside that band. What has not happened is a broad market correction downward: demand remains high and supply, while improving since the shortages of 2023 and 2024, has not flooded the market to a point where prices have noticeably dropped.

Eli Lilly's decision to increase Mounjaro's UK list price from around £122 to around £330 per four-week pen from September 2025 (as widely reported at the time) pushed the whole GLP-1 private market into a higher bracket. Wegovy and Mounjaro are different medicines, but they compete for the same patients, and when one anchor price moves sharply, the broader market feels it. For a fuller picture of how these prices compare across doses, the Wegovy price breakdown page sets out what different dose levels have typically cost private patients in the UK.

NICE's appraisal of semaglutide for weight management, TA875, covers NHS access, but NHS Wegovy is routed through specialist weight management services with significant eligibility criteria and waiting times, so private pricing remains the relevant question for most people reading this.

What do headline Wegovy prices usually leave out?

This is where comparison becomes genuinely tricky. A low headline figure for Wegovy sometimes covers only the medicine itself. What it may not include: the consultation fee charged to assess your suitability, the prescription fee, delivery charges, and any ongoing clinical support if you have a concern mid-treatment. Add those separately and the gap between a seemingly cheap provider and a fully inclusive one narrows or disappears entirely.

It is also worth knowing that for a prescription-only medicine, the consultation is not a formality you can skip. A prescriber must assess your health history, current medications, BMI and any relevant conditions before deciding whether treatment is appropriate. Services that appear to charge very little often either pass those costs through separately or omit the clinical review step in ways that should raise questions. If you want to understand what a genuinely transparent price looks like, the cheaper Wegovy guide walks through how to compare quotes fairly.

One detail worth checking before you commit to any provider: you can verify whether they operate from a registered pharmacy using the GPhC register at pharmacyregulation.org. It takes about thirty seconds and tells you a great deal.

Where does nume sit on price, and why?

A real clinician (a GPhC-registered Independent Prescriber) reads every consultation at nume before any prescription is issued. That review happens the same day you submit. If you order before noon on a working day and your prescriber approves treatment, your medicine leaves our GPhC-registered pharmacy that afternoon, arriving via DPD the next working day in packaging that gives nothing away. Our pharmacy and clinical team are set up to be fast and thorough, not the cheapest listing on a comparison page.

Our price covers the consultation, the prescription, the medicine, delivery and seven-day-a-week aftercare. There are no add-ons, no subscription and no automatic renewal: every repeat order is clinically reviewed before it goes out. We do not offer discount codes, promotional vouchers or sale pricing on prescription medicines, and we are not going to. Cheapest isn't a race we entered deliberately. What we offer instead is a clear, all-in price alongside a safety infrastructure that includes photo-ID verification, live weight checks on video and GP notification in line with GPhC guidance. You can see current treatment pricing through the free consultation page rather than in body copy, because the only fair comparison is the full-service price.

If you want a broader view of what is included in private weight-loss treatment at different price points, the weight management overview covers your options.

Is 'cheapest' even the right question for a prescription medicine?

Probably not. The MHRA has issued repeated warnings about fake weight-loss pens sold online, counterfeit products that have caused real harm, including hospitalisations. In October 2025 the first UK site manufacturing counterfeit tirzepatide pens was raided in Northampton, and enforcement through 2025 accounted for roughly 20 million doses of illegally traded weight-loss medicines with a street value of around £45 million. The MHRA's Yellow Card scheme allows anyone to report a suspect seller.

The pattern that precedes a bad outcome is usually the same: a price that looks too good, a seller who can't be found on the GPhC register, and a product supplied without a proper clinical assessment. For people asking how to get Wegovy more cheaply, the honest answer is that there are legitimate ways to get Wegovy cheap (timing your orders, understanding the dose schedule, using a service that includes everything rather than billing separately) and there are routes that look cheap because corners are being cut on safety. Whether Wegovy will get cheaper in the UK depends on factors including manufacturer pricing decisions and how competitive the private market becomes, and for anyone watching the longer-term picture, it is also worth reading about whether Wegovy is going to get cheaper as the GLP-1 landscape continues to shift.

The right measure for a prescription medicine is not price per pen. It is whether the medicine is genuine, prescribed following a proper clinical assessment, dispensed from a registered pharmacy, and supported by someone you can contact if something doesn't feel right. If you want to explore what that looks like in practice, check your eligibility with our prescribers. The consultation is free.